Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Brain : a Journal of Neurology|February 25, 2005
Subdural recordings of the mismatch negativity (MMN) in patients with focal epilepsyTimm Rosburg, Peter Trautner, Thomas Dietl, et al.
Brain Pathology (Zurich, Switzerland)|December 6, 2003
Molecular characterization of BCL6 breakpoints in primary diffuse large B-cell lymphomas of the central nervous system identifies GAPD as novel translocation partnerManuel Montesinos-Rongen, Takashi Akasaka, Reina Zühlke-Jenisch, et al.
Journal of Neuropathology and Experimental Neurology|October 22, 2002
Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous systemManuel Montesinos-Rongen, Reina Zühlke-Jenisch, Stefan Gesk, et al.
Journal of Neuropathology and Experimental Neurology|July 4, 2008
Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphomaCornelius Courts, Manuel Montesinos-Rongen, Anna Brunn, et al.
Fetal Diagnosis and Therapy|February 24, 2006
Percutaneous fetoscopic patch coverage of spina bifida aperta in the human--early clinical experience and potentialThomas Kohl, Rudolph Hering, Axel Heep, et al.
Journal of Neuropathology and Experimental Neurology|March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expressionCornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapyHendrik Pels, Ingo G H Schmidt-Wolf, Axel Glasmacher, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Pageof 5